| Product Code: ETC7649410 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Cyclooxygenase 2 Inhibitor Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle |
3.4 Israel Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces |
3.5 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Cyclooxygenase 2 Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring long-term pain management |
4.2.2 Growing awareness about the benefits of cyclooxygenase 2 inhibitors in managing pain and inflammation |
4.2.3 Rising geriatric population in Israel leading to higher demand for pain management medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and marketing of cyclooxygenase 2 inhibitors |
4.3.2 Potential side effects and safety concerns associated with long-term use of these drugs |
4.3.3 Competition from alternative pain management therapies and medications |
5 Israel Cyclooxygenase 2 Inhibitor Market Trends |
6 Israel Cyclooxygenase 2 Inhibitor Market, By Types |
6.1 Israel Cyclooxygenase 2 Inhibitor Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2021- 2031F |
6.1.4 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2021- 2031F |
6.1.5 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2021- 2031F |
6.1.6 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2021- 2031F |
6.1.7 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Cyclooxygenase 2 Inhibitor Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2021- 2031F |
6.2.3 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2021- 2031F |
6.3 Israel Cyclooxygenase 2 Inhibitor Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.3.3 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2021- 2031F |
6.3.4 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Cyclooxygenase 2 Inhibitor Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Cyclooxygenase 2 Inhibitor Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Israel Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Cyclooxygenase 2 Inhibitor Market Import-Export Trade Statistics |
7.1 Israel Cyclooxygenase 2 Inhibitor Market Export to Major Countries |
7.2 Israel Cyclooxygenase 2 Inhibitor Market Imports from Major Countries |
8 Israel Cyclooxygenase 2 Inhibitor Market Key Performance Indicators |
8.1 Patient adherence rate to cyclooxygenase 2 inhibitor treatment |
8.2 Number of new product launches and innovations in the cyclooxygenase 2 inhibitor market |
8.3 Rate of prescription by healthcare professionals for cyclooxygenase 2 inhibitors |
9 Israel Cyclooxygenase 2 Inhibitor Market - Opportunity Assessment |
9.1 Israel Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Israel Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Israel Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Israel Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Cyclooxygenase 2 Inhibitor Market - Competitive Landscape |
10.1 Israel Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2024 |
10.2 Israel Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here